相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Altered Glutamate Protein Co-Expression Network Topology Linked to Spine Loss in the Auditory Cortex of Schizophrenia
Matthew L. MacDonald et al.
BIOLOGICAL PSYCHIATRY (2015)
Psychopharmacological Treatment of Neurocognitive Deficits in People with Schizophrenia: A Review of Old and New Targets
Anthony O. Ahmed et al.
CNS DRUGS (2014)
Targeting of NMDA receptors in new treatments for schizophrenia
Kenji Hashimoto
EXPERT OPINION ON THERAPEUTIC TARGETS (2014)
The Selective Glycine Uptake Inhibitor Org 25935 as an Adjunctive Treatment to Atypical Antipsychotics in Predominant Persistent Negative Symptoms of Schizophrenia Results From the GIANT Trial
Joep H. Schoemaker et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2014)
Neurocognition in schizophrenia: From prodrome to multi-episode illness
Valentina Corigliano et al.
PSYCHIATRY RESEARCH (2014)
2 Neurocognitive predictors of remission of symptoms and social and role functioning in the early course of first-episode schizophrenia
Anne-Kari Torgalsboen et al.
PSYCHIATRY RESEARCH (2014)
D-Cycloserine augmentation of cognitive remediation in schizophrenia
Christopher K. Cain et al.
SCHIZOPHRENIA RESEARCH (2014)
Glutamatergic abnormalities in schizophrenia: A review of proton MRS findings
Eline M. P. Poels et al.
SCHIZOPHRENIA RESEARCH (2014)
Minocycline supplementation for treatment of negative symptoms in early-phase schizophrenia: A double blind, randomized, controlled trial
Fang Liu et al.
SCHIZOPHRENIA RESEARCH (2014)
A Role for Picomolar Concentrations of Pregnenolone Sulfate in Synaptic Activity-Dependent Ca2+ Signaling and CREB Activation
Conor C. Smith et al.
MOLECULAR PHARMACOLOGY (2014)
Adjunctive pharmacotherapy for cognitive deficits in schizophrenia: meta-analytical investigation of efficacy
Kee-Hong Choi et al.
BRITISH JOURNAL OF PSYCHIATRY (2013)
Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders
Kenji Hashimoto et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2013)
AMPARs and Synaptic Plasticity: The Last 25 Years
Richard L. Huganir et al.
NEURON (2013)
Feasibility, Safety, and Efficacy of the Combination of D-Serine and Computerized Cognitive Retraining in Schizophrenia: An International Collaborative Pilot Study
Deepak C. D'Souza et al.
NEUROPSYCHOPHARMACOLOGY (2013)
The relevance of cognitive, clinical and premorbid variables in predicting functional outcome for individuals with first-episode psychosis: A 3 year longitudinal study
Rosa Ayesa-Arriola et al.
PSYCHIATRY RESEARCH (2013)
Proton magnetic resonance spectroscopy of the substantia nigra in schizophrenia
Meredith A. Reid et al.
SCHIZOPHRENIA RESEARCH (2013)
Increased Hippocampal Glutamate and Volumetric Deficits in Unmedicated Patients With Schizophrenia
Nina V. Kraguljac et al.
JAMA PSYCHIATRY (2013)
Add-on Treatment of Benzoate for Schizophrenia A Randomized, Double-blind, Placebo-Controlled Trial of D-Amino Acid Oxidase Inhibitor
Hsien-Yuan Lane et al.
JAMA PSYCHIATRY (2013)
Elevated Prefrontal Cortex γ-Aminobutyric Acid and Glutamate-Glutamine Levels in Schizophrenia Measured In Vivo With Proton Magnetic Resonance Spectroscopy
Lawrence S. Kegeles et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Clozapine, but not haloperidol, enhances glial d-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes
Shunske Tanahashi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
NO CORRELATION BETWEEN PLASMA NMDA-RELATED GLUTAMATERGIC AMINO ACID LEVELS AND COGNITIVE FUNCTION IN MEDICATED PATIENTS WITH SCHIZOPHRENIA
Tohru Ohnuma et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE (2012)
A Multicenter, Add-On Randomized Controlled Trial of Low-Dosed-Serine for Negative and Cognitive Symptoms of Schizophrenia
Mark Weiser et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
A preliminary, randomized, double-blind, placebo-controlled trial of L-carnosine to improve cognition in schizophrenia
K. N. Roy Chengappa et al.
SCHIZOPHRENIA RESEARCH (2012)
Effects of body position, imaging plane, and observer on computed tomographic measurements of the lumbosacral intervertebral foraminal area in dogs
Brent M. Higgins et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2011)
Glutamate as a Marker of Cognitive Function in Schizophrenia: A Proton Spectroscopic Imaging Study at 4 Tesla
Juan R. Bustillo et al.
BIOLOGICAL PSYCHIATRY (2011)
International Consensus Study of Antipsychotic Dosing
David M. Gardner et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Strategies to Enhance N-Methyl-D-Aspartate Receptor-Mediated Neurotransmission in Schizophrenia, a Critical Review and Meta-Analysis
Guochuan E. Tsai et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
A randomized, double-blind, placebo-controlled comparison study of sarcosine (N-methylglycine) and D-serine add-on treatment for schizophrenia
Hsien-Yuan Lane et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
A Double-Blind, Randomized Study of Minocycline for the Treatment of Negative and Cognitive Symptoms in Early-Phase Schizophrenia
Yechiel Levkovitz et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Specific metabolites in the medial prefrontal cortex are associated with the neurocognitive deficits in schizophrenia: A preliminary study
Yukihiko Shirayama et al.
NEUROIMAGE (2010)
High dose D-serine in the treatment of schizophrenia
Joshua T. Kantrowitz et al.
SCHIZOPHRENIA RESEARCH (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Proof-of-Concept Trial with the Neurosteroid Pregnenolone Targeting Cognitive and Negative Symptoms in Schizophrenia
Christine E. Marx et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: A meta-analysis
Joseph Ventura et al.
SCHIZOPHRENIA RESEARCH (2009)
N-acetyl cysteine as a glutathione precursor for schizophrenia - A double-blind, randomized, placebo-controlled trial
Michael Berk et al.
BIOLOGICAL PSYCHIATRY (2008)
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Gerard Sanacora et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Minocycline increases phosphorylation and membrane insertion of neuronal GluR1 receptors
Marta Imbesi et al.
NEUROSCIENCE LETTERS (2008)
Antipsychotic drugs: Comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection
Jeffrey A. Lieberman et al.
PHARMACOLOGICAL REVIEWS (2008)
Neurochemical and structural correlates of executive dysfunction in schizophrenia
Nicolas Ruesch et al.
SCHIZOPHRENIA RESEARCH (2008)
A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia
Donald C. Goff et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Mutations in ionotropic AMPA receptor 3 alter channel properties and are associated with moderate cognitive impairment in humans
Ye Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: A proton magnetic resonance spectroscopy study
Patricia Ohrmann et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2007)
Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia - Is it a practice effect?
Terry E. Goldberg et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
The Cognitive and Negative Symptoms in Schizophrenia, Trial (CONSIST): The efficacy of glutamatergic agents for negative symptoms and cognitive impairments
Robert W. Buchanan et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Double-blind, placebo-controlled, crossover trial of clozapine plus glycine in refractory schizophrenia negative results
P Diaz et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2005)
Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: A longitudinal first-episode study with 7-year follow-up
P Milev et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Comparative effects of glycine and D-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis
U Heresco-Levy et al.
SCHIZOPHRENIA RESEARCH (2004)
Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria
MF Green et al.
BIOLOGICAL PSYCHIATRY (2004)
Effects of D-cycloserine on negative symptoms in schizophrenia
EJ Duncan et al.
SCHIZOPHRENIA RESEARCH (2004)
NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex
ME Jackson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Modeling the early course of schizophrenia
H Hafner et al.
SCHIZOPHRENIA BULLETIN (2003)
A placebo-controlled pilot study of the ampakine CX516 added to clozapine in schizophrenia
DC Goff et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2001)
Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia
HM Ibrahim et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis
S Duval et al.
BIOMETRICS (2000)
Glutamate receptor expression in schizophrenic brain
JH Meador-Woodruff et al.
BRAIN RESEARCH REVIEWS (2000)
分享论文
